2019
The ALT-70 cellulitis model maintains predictive value at 24 and 48 hours after presentation
Singer S, Li DG, Gunasekera N, Okhovat JP, Vedak P, Weng C, Cohen J, Joyce C, Raff A, Kroshinsky D, Mostaghimi A. The ALT-70 cellulitis model maintains predictive value at 24 and 48 hours after presentation. Journal Of The American Academy Of Dermatology 2019, 81: 1252-1256. PMID: 30914341, DOI: 10.1016/j.jaad.2019.03.050.Peer-Reviewed Original Research
2016
Cost-effectiveness of Confirmatory Testing Before Treatment of Onychomycosis
Mikailov A, Cohen J, Joyce C, Mostaghimi A. Cost-effectiveness of Confirmatory Testing Before Treatment of Onychomycosis. JAMA Dermatology 2016, 152: 1-6. PMID: 26716567, DOI: 10.1001/jamadermatol.2015.4190.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, OralAdministration, TopicalAlgorithmsCost SavingsCost-Benefit AnalysisDecision Support TechniquesDecision TreesHealth Care CostsHumansHydroxidesNaphthalenesOnychomycosisPeriodic Acid-Schiff ReactionPotassium CompoundsPotentially Inappropriate Medication ListTerbinafineTriazolesConceptsConfirmatory testingOral terbinafineSystemic therapyDirect patient evaluationLiver toxic effectsPatient cost savingsPotassium hydroxide (KOH) stainDisease prevalenceTreatment of onychomycosisConfirmatory diagnostic testingHealth care professionalsPrevalence of diseaseTerbinafine therapyEmpirical therapyPretreatment testingPrimary outcomePatient evaluationSpecific therapyEmpirical treatmentMAIN OUTCOMECare professionalsInternational guidelinesTherapyDiagnostic testingPatient safety